FDA Adverse Event Malfunction Summary report: N

MAYFIELD MODIFIED SKULL CLAMP

MDR report key: 9167388 · Received October 8, 2019

Report

Report Number
3004608878-2019-01044
Event Type
Malfunction
Date Received
October 8, 2019
Date of Event
September 16, 2019
Report Date
September 16, 2019
Manufacturer
INTEGRA LIFESCIENCES CORPORATION OH/USA
Product Code
HBL
PMA / PMN Number
PRE-AMEND
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION - THE DEVICE WAS NOT RETURNED FOR EVALUATION. FAILURE ANALYSIS CANNOT BE COMPLETED DUE TO THE LACK OF INFORMATION RECEIVED TO PERFORM A COMPLETE INVESTIGATION. A DHR REVIEW CANNOT BE PERFORMED AT THIS TIME AS THE SERIAL NUMBER PROVIDED (B)(6) DOES NOT APPEAR TO BE A VALID INTEGRA NUMBER. THE REPORTED COMPLAINT UNCONFIRMED. ROOT CAUSE ANALYSIS CANNOT BE COMPLETED AT THE MOMENT. BETWEEN 05NOV2019 AND 30JUN2020, APPROXIMATELY 2,200 MDRS SUBMITTED ELECTRONICALLY BY INTEGRA LIFESCIENCES VIA TRACKWISE, INTEGRA'S COMPLAINT HANDLING SYSTEM, WERE NOT RECEIVED BY CDRH DUE TO A COMPUTER SYSTEM ISSUE. WITHIN THIS TIME PERIOD, AN ERROR WITH INTEGRA'S MIDDLEWARE, WHICH FACILITATES COMMUNICATIONS BETWEEN TRACKWISE AND THE FDA SYSTEM, CAUSED THE COMPLAINT RECORDS TO CLOSE AND INDICATE WE HAD RECEIVED AN ACKNOWLEDGEMENT 3 FROM THE FDA WHEN WE HAD NOT. INTEGRA INTERPRETED THE ACKNOWLEDGEMENT AS A SUCCESSFUL SUBMISSION; HOWEVER, SUBSEQUENT INVESTIGATION REVEALED THE ACKNOWLEDGEMENT 3 RECEIVED WAS FROM OUR MIDDLEWARE AND NOT FROM THE FDA (THESE ACKNOWLEDGEMENTS HAVE BEEN RETAINED AS PART OF THE DOCUMENTATION OF THE MDR). THE MALFUNCTION WAS RELATED TO THE RELOCATION OF THE TRACKWISE APPLICATION TO A NEW DATA CENTER DURING THE TRANSITION OF INTEGRA'S CORPORATE HEADQUARTERS FROM PLAINSBORO, NJ TO PRINCETON, NJ. PREVIOUSLY, INTEGRA HAD BEEN SUCCESSFULLY RECEIVING ACKNOWLEDGEMENTS 1, 2, AND 3 FROM THE FDA, AND OUR RECORDS REFLECT THESE ACKNOWLEDGEMENTS, INCLUDING THE DATE AND TIME STAMPS. CAPA PR 229048 AND NC 20-011 HAVE BEEN OPENED BY INTEGRA TO FURTHER INVESTIGATE THE NONCONFORMANCE AND DEVELOP A CORRECTIVE ACTION PLAN. THE MIDDLEWARE ERROR HAS BEEN CORRECTED, AND INTEGRA HAS FILED MDRS SINCE THE CORRECTION AND VERIFIED THAT THE APPROPRIATE ACKNOWLEDGEMENTS HAVE BEEN RECEIVED FROM THE FDA. INTEGRA IS RESUBMITTING ALL IMPACTED MDR REPORTS FOR THE TIME PERIOD 05NOV2019 THROUGH 30JUN2020. INTEGRA LIFESCIENCES CONTACTED (B)(6) , DIRECTOR OF REGULATORY PROGRAMS, OFFICE OF PRODUCT EVALUATION AND QUALITY AND (B)(6) , ASSISTANT DIRECTOR, MDR TEAM, OFFICE OF PRODUCT EVALUATION AND QUALITY ON JULY 8-9, 2020 TO REPORT THESE ISSUES REGARDING MDR REPORTS.

Description of Event or Problem · 0

N/A.

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT YET RETURNED TO THE MANUFACTURER FOR ANALYSIS. THE PLANT INVESTIGATION IS IN PROGRESS AND A SUPPLEMENTAL MEDWATCH REPORT WILL BE SUBMITTED UPON COMPLETION OF THE INVESTIGATION.

Description of Event or Problem · 1

A SALES REPRESENTATIVE REPORTED ON BEHALF OF THE CUSTOMER THAT THE A1059 MAYFIELD MODIFIED SKULL CLAMP HAD A STICKING ISSUE FOR A CRANIAL PROCEDURE ON (B)(6) 2019. THE CLAMP RATCHET TEETH WERE STICKING, DIFFICULT TO MOVE, AND DIFFICULT TO APPLY ON THE PATIENT'S HEAD. THE PRODUCT MALFUNCTIONED BUT DID NOT RESULT IN PATIENT OR USER INJURY NOR DID IT RESULT TO DEATH. THE ISSUE WAS NOTICED PRIOR TO SURGERY. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
959633 MAYFIELD MODIFIED SKULL CLAMP SKULL CLAMPS AND HEADREST SYSTEMS HBL INTEGRA LIFESCIENCES CORPORATION OH/USA

Patients

Seq Age Sex Outcome Treatment
1